Clinical Trial Update: Efficacy and Safety of Shexiang Baoxin Pill in Patients With Ischemia With Non-Obstructive Coronary Artery [Phase 4]

View source ↗

Summary

Clinical trial update reporting on the efficacy and safety of Shexiang Baoxin Pill in ischemia with non-obstructive coronary artery disease (INOCA) and angina, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Coronary Heart Disease
• Ischemia with Non-obstructive Coronary Disease

Drugs mentioned

• Shexiang Baoxin Pill

Snippet

Sponsor: Shanghai Hutchison Pharmaceuticals Limited | Conditions: Ischemia With Non-Obstructive Coronary Artery, Angina Pectoris | Phase 4 | Status: COMPLETED